Edesa Biotech Inc expected to post a loss of 37 cents a share - Earnings Preview

Edesa Biotech

24/12/2021 13:31

* Edesa Biotech Inc  EDSA.OQ   EDSA.O  is expected to show a
fall in quarterly revenue when it reports  results on December
27 (estimated). 
​* Refinitiv's mean analyst estimate for Edesa Biotech Inc is
for a loss of 37 cents per share. For the same quarter last
year, the company reported a loss of 22 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Edesa Biotech
Inc is $18​, about 64.1% above​ its last closing price
of $6.47. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2021  -0.32       -0.32      -0.36     Missed  -12.5
 Mar. 31 2021  -0.29       -0.29      -0.81     Missed  -174.6
 Dec. 31 2020  -0.19       -0.19      -0.26     Missed  -36.8​
 Sep. 30 2020  -0.21       -0.20      -0.22     Missed  -7.3
 ​​Jun.        -0.23       -0.20      -0.20     Met     2.4
 30 2020                                                
 Mar. 31 2020  -0.19       -0.19      -0.17     Beat    10.5​
 This summary was machine generated December 24 at 13:31 GMT. 
All figures in US dollars  unless otherwise stated